Evaluation of PPP2R2A as a prostate cancer susceptibility gene: A comprehensive germline and somatic study

Cancer Genetics

Volumn 204, Issue 7, 2011, Pages 375-381

  Cheng, Yu ^a   Liu, Wennuan ^a   Kim, Seong Tae ^a   Sun, Jishan ^a   Lu, Lingyi ^a   Sun, Jielin ^a   Zheng, Siqun Lilly ^a   Isaacs, William B ^b   Xu, Jianfeng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Homozygous deletion; PPP2R2A; Prostate cancer

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE 2; PROSTATE SPECIFIC ANTIGEN; DNA; PPP2R2A PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GERM LINE; GLEASON SCORE; HEREDITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PPP2R2A GENE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; TUMOR SUPPRESSOR GENE; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; EXON; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PROSTATE TUMOR;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ALLELES; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENE DELETION; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROTEIN PHOSPHATASE 2;

EID: 80054801896     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.05.002     Document Type: Article

References (31)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Schaid D.J. The complex genetic epidemiology of prostate cancer. Human Mol Genet 2004, 13:R103-R121.
3. Easton D.F., Schaid D.J., Whittemore A.S., et al. Where are the prostate cancer genes?-A summary of eight genome wide searches. Prostate 2003, 57:261-269.
4. Xu J., Zheng S.L., Hawkins G.A., et al. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet 2001, 69:341-350.
5. Goddard K.A., Witte J.S., Suarez B.K., et al. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001, 68:1197-1206.
6. Wiklund F., Jonsson B.A., Göransson I., et al. Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23. Hum Genet 2003, 112:414-418.
7. Janer M., Friedrichsen D.M., Stanford J.L., et al. Genomic scan of 254 hereditary prostate cancer families. Prostate 2003, 57:309-319.
8. Matsui H., Suzuki K., Ohtake N., et al. Genomewide linkage analysis of familial prostate cancer in the Japanese population. J Hum Genet 2004, 49:9-15.
9. Maier C., Herkommer K., Hoegel J., et al. A genomewide linkage analysis for prostate cancer susceptibility genes in families from Germany. Eur J Hum Genet 2005, 13:352-360.
10. Bookstein R. Tumor suppressor genes in prostate cancer. Prostate cancer, biology, genetics 2001, 61-93. Human Press, Totowa, New Jersey. L.W.K. Chung, W.B. Isaacs, J.W. Simons (Eds.).
11. Chang B.L., Liu W., Sun J., et al. Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p. Cancer Res 2007, 6:4098-4103.
12. Liu W., Xie C.C., Zhu Y., et al. Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia 2008, 10:897-907.
13. Janssens V., Goris J., Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 2005, 15:34-41.
14. Jin Y., Mertens F., Kullendorff C.M., et al. Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma. Neoplasia 2006, 8:413-418.
15. Liu X., Sempere L.F., Ouyang H., et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010, 120:1298-1309.
16. Wang S.S., Esplin E.D., Li J.L., et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998, 282:284-287.
17. Calin G.A., di Iasio M.G., Caprini E., et al. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000, 19:1191-1195.
18. Jones S., Wang T.L., Shih IeM, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010, 330:228-231.
19. Xu J., Gillanders E.M., Isaacs S.D., et al. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 2003, 57:320-325.
20. Zheng S.L., Sun J., Cheng Y., et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007, 99:1525-1533.
21. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
22. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
23. Marchini J., Howie B., Myers S., et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007, 39:906-913.
24. Takagi Y., Futamura M., Yamaguchi K., et al. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. Gut 2000, 47:268-271.
25. Colella S., Ohgaki H., Ruediger R., et al. Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genes. Int J Cancer 2001, 93:798-804.
26. Suzuki K., Takahashi K. Reduced expression of the regulatory A subunit of serine/threonine protein phosphatase 2A in human breast cancer MCF-7 cells. Int J Oncol 2003, 23:1263-1268.
27. Healy A.M., Zolnierowicz S., Stapleton A.E., et al. CDC55, a S. cerevisiae gene involved in cellular morphogenesis: identification, characterisation, and homology to the B subunit of mammalian type 2A protein phosphatase. Mol Cell Biol 1991, 11:5767-5780.
28. Mayer-Jaekel R.E., Ohkura H., Gomes R., et al. The 55 kd regulatory subunit of Drosophila protein phosphatase 2A is required for anaphase. Cell 1993, 72:621-633.
29. Turowski P., Myles T., Hemmings B.A., et al. Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell 1999, 10:1997-2015.
30. Arroyo J.D., Hahn W.C. Involvement of PP2A in viral and cellular transformation. Oncogene 2005, 24:7746-7755.
31. Kuo Y.C., Huang K.Y., Yang C.H., et al. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 2008, 283:1882-1892.